Scientific Sessions
  • #AHA21
  • #ReSS21
  • #QCOR21
  • Virtual Experience Access
  • Sessions & QCOR Posters
  • ReSS Posters
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Program
  • Previews
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Program
  • Previews
Resources
  • #AHA21
  • #ReSS21
  • #QCOR21
  • Virtual Experience Access
  • Sessions & QCOR Posters
  • ReSS Posters
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter iconFacebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Live Meeting Image
AHA21
Member Connect
An online gathering place for Association Members
Dec 13th, 2021
P104 Steven Botts Image
AHA21
Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells
Dec 13th, 2021
(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA
AHA21
The latest science in heart failure
Nov 15th, 2021
(From left to right): Danielle Belardo, MD, Rafael Diaz, MD, and Christie Mitchell Ballantyne, MD, FAHA
AHA21
Trials’ results highlight the potential for fish oil to fight COVID-19 and MK-0616 to lower cholesterol
Nov 15th, 2021
(left to right): Jacqueline E. Tamis-Holland, MD, and Jane Armitage, FRCP, FFPH, OBE
AHA21
New drugs, indications in cardiovascular disease
Nov 15th, 2021
Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Nov 14th, 2021
Marko Banovic, MD, PhD
AHA21
Valves, veins and new viewpoints in cardiothoracic surgery
Trials’ results shed light on a new device for extending vein graft durability, the timing of bypass surgery after Ticagrelor cessation and aortic valve replacement, and best practices for concomitant tricuspid valve repair.
Nov 13th, 2021
Download your Event Guide
Sponsored
Download your Event Guide
May 10th, 2022
21 10 25 Aha Learning Studio Virtual Doctor Bag Insert Pdf Final
Sponsored Content
The heart of the matter
A new treatment for slowing CKD progression and reducing CV risk in patients with CKD associated with T2D
Nov 13th, 2021
Getty Images 537596177
Late-Breaking Science
LBS coverage (2020): AF trials reveal pragmatic screening and intervention opportunities
Nov 16th, 2020